Perpetual Ltd’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$582K Sell
3,879
-759
-16% -$82.5K 0.01% 306
2026
Q1
$428K Buy
4,638
+301
+7% +$30.2K 0.01% 341
2025
Q4
$443K Buy
+4,337
New +$388K 0.01% 323
2020
Q3
$1.13M Sell
10,100
-3,500
-26% -$320K 0.08% 183
2020
Q2
$1.1M Buy
+13,600
New +$1.1M 0.1% 132

Other funds holding GH

Perpetual Ltd's GH Position: Q2 2026 in Review

Perpetual Ltd reduced its Guardant Health (GH) stake by 16% in Q2 2026, selling an estimated $82.5K and leaving 3,879 shares worth $582K. The position accounts for 0.01% of the portfolio, ranked #306.

Perpetual Ltd first reported a position in GH in Q2 2020 and has held it in 5 quarters since. The position peaked at $1.13M in Q3 2020. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Perpetual Ltd held 3,879 shares of Guardant Health worth $582K as of Q2 2026.
  • Perpetual Ltd sold 759 Guardant Health shares in Q2 2026, an estimated $82.5K.
  • Guardant Health made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #306 holding.
  • Perpetual Ltd first reported a position in Guardant Health in Q2 2020 and has held it in 5 quarters since.
  • Perpetual Ltd's Guardant Health position peaked at $1.13M in Q3 2020.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.